About Invoke Capital
Invoke Capital is a venture capital firm founded in 2012. It is primarily based out of London, United Kingdom. As of Feb 2019, Invoke Capital has invested in 6 companies. It primarily invests in Series A round in United Kingdom based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Enterprise Infrastructure. Most recently it participated in the $***** Series B round of Luminance Overall, Invoke Capital portfolio has seen 1 IPO and 2 acquisitions, namely Darktrace, Featurespace and Sophia Genetics. A lot of funds co-invest with Invoke Capital, with names like Slaughter and May sharing a substantial percentage of its portfolio. Invoke Capital has team of 1 people including 1 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 2 more
Portfolio IPOs
Portfolio Acquisitions
Invoke Capital's List of Top Investments
Invoke Capital has a portfolio of 6 companies. Their most notable investments are in Sophia Genetics and Luminance.Their portfolio spans across United Kingdom and Switzerland. They have invested in Enterprise Applications, High Tech, Enterprise Infrastructure and 2 other sectors, across stages such as Seed, Series A and 2 more. Here is the list of top investments by Invoke Capital:
1. Darktrace
Developer of artificial intelligence software for automated enterprise cybersecurity defense. This technology monitors network traffic, email communications, cloud environments, and endpoint devices to identify and respond to potential threats. The software utilizes machine learning to establish patterns of normal activity and detects deviations that may indicate malicious behavior. It provides tools for incident investigation, threat triage, and autonomous response to mitigate risks across digital infrastructure. The system integrates with existing security stacks to provide visibility and protection against various attack vectors.
Key facts about Darktrace
- Founded Year: 2013
- Location: Cambridge (United Kingdom)
- Annual Revenue: £500M - £1B as on Jun 30, 2025
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $239M
- Employee Count: 2,607 as on May 31, 2026
- Investors: Fresher Ventures, Vitruvian Partners and 19 Others
- Latest Funding Round: Series E, Jul 16, 2019, $*****
- Highlight: Acquired
2. Luminance
AI based platform for contract analytics and due diligence. The platform uses AI to automatically read and understand hundreds of pages of complex legal documentation. It helps in identifying potential risks in the data room, uncovering anomalies or even missing data, and in prioritizing review and allocation of tasks. Core features include clause identification, data visualizer, and anomaly detection. It has been trained by legal experts to accurately identify and label documents, clauses, people, places, and language, and not just keyword search.
Key facts about Luminance
- Founded Year: 2015
- Location: London (United Kingdom)
- Annual Revenue: £10M - £50M as on Dec 31, 2024
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $165M
- Employee Count: 459 as on Jun 30, 2026
- Investors: RPS Ventures, Invoke Capital and 10 Others
- Latest Funding Round: Series C, Feb 18, 2025, $*****
- Highlight: Editors' Pick
3. Featurespace
Developer of risk management and fraud prevention software solutions. The company provides a platform designed to model and predict individual behavior in real time. This platform is used for fraud prevention and anti-money laundering purposes. It allows computers to understand when an individual customer’s behavior is out of character. The platform evaluates risk automatically.
Key facts about Featurespace
- Founded Year: 2008
- Location: Cambridge (United Kingdom)
- Annual Revenue: £50M - £100M as on Dec 31, 2024
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $111M
- Employee Count: 283 as on May 31, 2026
- Investors: Merian Global Investors, Highland Europe and 24 Others
- Latest Funding Round: Grant (prize money), Nov 22, 2022, $*****
- Highlight: Acquired
Provider of artificial intelligence software for analyzing complex medical data. This technology platform processes genomic, radiomic, and multimodal health information to assist clinicians and researchers. It facilitates the identification of actionable insights for patients diagnosed with cancer or rare inherited disorders. The system integrates diverse health datasets to support clinical decision-making and drug development processes. By standardizing workflows and interpreting biological information, the software enables healthcare institutions to manage diagnostic challenges. The platform serves oncologists, pathologists, and geneticists by providing tools for variant analysis and clinical trial optimization. It operates as a centralized resource for managing health information while maintaining regulatory compliance and data security standards.
Key facts about Sophia Genetics
- Founded Year: 2011
- Location: Rolle (Switzerland)
- Stage: Public
- Total Funding till date: $249M
- Employee Count: 517 as on Jun 30, 2026
- Investors: Generation Investment Management, Endeavour Vision and 24 Others
- Latest Funding Round: Series F, Oct 01, 2020, $*****
- Highlight: Public
5. Neurence
Provider of business intelligence software. The company is developing an Intelligent cloud-based recognition engine allowing computers to understand unstructured human environments.
Key facts about Neurence
- Founded Year: 2012
- Location: Cambridge (United Kingdom)
- Stage: Series A
- Total Funding till date: $4M
- Employee Count: 2 as on Jun 30, 2025
- Investors: Invoke Capital
- Latest Funding Round: Series A, Dec 03, 2013, $*****
Invoke Capital's Year-on-Year Investment Trends
Invoke Capital has invested in 6 companies over the last 13 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in Featurespace and most recent follow-on round was in Luminance.Invoke Capital's Investments by Stage
Invoke Capital has made 2 investments in Seed stage, 2 investments in Series A stage with an average round size of $3.5M, 1 investment in Series B stage with an average round size of $13.8M and 1 investment in Series C stage with an average round size of $21.9M.Stage of entry | No. of Investments |
|---|---|
Seed | 2 |
Series A | 2 |
Series B | 1 |
Series C | 1 |
Note: We have considered here, only first round of investments
Invoke Capital's Investments by Sector
Invoke Capital has a diverse portfolio, with companies operating in the Enterprise Applications, Artificial Intelligence - Industry Applications, Enterprise Infrastructure, High Tech and Vertical SaaS. Notably, it has invested in 6 Enterprise (B2B) companies, 6 Tech companies, 5 Software companies and at least 4 companies focusing on Saas.Sector | No. of Investments |
|---|---|
Enterprise Applications | 5 |
Artificial Intelligence - Industry Applications | 2 |
Enterprise Infrastructure | 2 |
High Tech | 2 |
Vertical SaaS | 2 |
Others | 3 |
Note: We have considered here, only first round of investments
Invoke Capital's Investments by Geography
Invoke Capital has made most investments in United Kingdom (5), followed by Switzerland where it has made 1 investment.Country | No. of Investments |
|---|---|
United Kingdom | 5 |
Switzerland | 1 |
Note: We have considered here, only first round of investments
Invoke Capital's recent investments
Invoke Capital has not made any investment in 2026 so far.Here are the most recent investments by Invoke Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 07, 2019 | United Kingdom | Series B | 5562 | [+1] | |
Jan 25, 2019 | United Kingdom | Series D | 2366 | [+5] | |
Nov 29, 2017 | United Kingdom | Series A | 2455 | [+1] | |
Sep 13, 2017 | Switzerland | Series D | 6900 | [+2] | |
Aug 01, 2017 | United Kingdom | Series C | 3102 | [+5] |
IPOs and Publicly Listed companies in Invoke Capital's Portfolio
1 of Invoke Capital's portfolio company became public - Sophia Genetics. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jul 2021 at marketcap of $1.14BHere are Invoke Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 23, 2021 | Jul 08, 2014 | Series B | 8785 |
Acquired companies in Invoke Capital's Portfolio
2 companies from Invoke Capital's portfolio have been acquired. The most recent acquisition was Featurespace in Sep 2024 by Visa for $*****.Here are Invoke Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Sep 26, 2024 | Aug 01, 2017 | Series C | 8929 | |
Apr 26, 2024 | Sep 16, 2013 | Seed | 9370 |
Team profile of Invoke Capital
Invoke Capital has a team of 1 member located in United Kingdom. Invoke Capital's team does not sit on the board of any company as of now.Co-investors of Invoke Capital
Over the past 13 years, 49 investors have co-invested in Invoke Capital's portfolio companies. This includes funds and angels.
- Invested before Invoke Capital: TTV Capital, Nesta Impact Investments and 5 others have invested in rounds before Invoke Capital. There is 1 company where TTV Capital has invested before Invoke Capital and 1 company where Nesta Impact Investments has invested before Invoke Capital.
- Top Co-investors of Invoke Capital: 7 investors entered a company along with Invoke Capital. These include investors like Slaughter and May (1 company).
- Invested after Invoke Capital: A total of 35 investors have invested in Invoke Capital's portfolio after their investments. Top Investors include Insight Partners (2 companies), Talis Capital (2 companies) and Summit Partners (1 company).
Recent News related to Invoke Capital
•
US VCs drive $32.3m global expansion round for Cambridge fraudbuster FeaturespaceBusiness Weekly newspaper•Jan 27, 2019•Featurespace, Insight Partners, MissionOG, Invoke Capital and 4 others
•
Luminance completes Series A funding round at $50M valuationLegal IT Professionals•Nov 29, 2017•Luminance, Talis Capital, Invoke Capital, Slaughter and May and 1 other
•
Talis leads $10m series-A for AI legal firm LuminanceUnquote•Nov 29, 2017•Luminance, Talis Capital, Invoke Capital, Slaughter and May
•
Worldpay Invests in Leading Machine Learning Fraud Prevention Company, FeaturespacePR Newswire•Oct 04, 2017•Featurespace, Highland Europe, Invoke Capital, Worldpay and 3 others
•
•
TECH Why Hire a Lawyer When a Robot Will Do?Bloomberg•Sep 22, 2016•Invoke Capital, Luminance, Ross Intelligence, Kira Systems
•
•
•
•
